Assenagon Asset Management
GEN

Assenagon Asset Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Assenagon Asset Management’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,029
Closed -$21K – 1011
2019
Q3 		$21K Sell
19,029
-28,060
-60% -$32.4K ﹤0.01% 807
2019
Q2 		$58K Buy
+47,089
New +$60K ﹤0.01% 974

Other funds holding GEN

VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Assenagon Asset Management's GEN Position: Q4 2019 in Review

Assenagon Asset Management sold out of Genesis Healthcare, Inc. (GEN) in Q4 2019, closing a stake of 19,029 shares — an estimated $21K sold.

Assenagon Asset Management first reported a position in GEN in Q2 2019 and held it in 2 quarters. The position peaked at $58K in Q2 2019. 69 funds tracked by Wall St. Rank hold GEN as of Q4 2019.

  • Assenagon Asset Management reported no remaining Genesis Healthcare, Inc. position as of Q4 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 19,029 Genesis Healthcare, Inc. shares in Q4 2019, an estimated $21K.
  • Assenagon Asset Management first reported a position in Genesis Healthcare, Inc. in Q2 2019 and held it in 2 quarters.
  • Assenagon Asset Management's Genesis Healthcare, Inc. position peaked at $58K in Q2 2019.
  • 69 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2019.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.